Bemethyl

Bemethyl

Bemethyl (also known as Bemitil or Metaprot) is a nootropic and adaptogen drug that was developed in the Soviet Union in the 1970s. It is classified as an actoprotector, a class of drugs that enhance physical performance and recovery after exercise.

History

Bemethyl was first synthesized in the 1970s by a team of scientists led by Nikolay Vasilevich Sklifasovsky at the All-Union Vitamins Scientific Research Institute in the Soviet Union. It was initially used by Soviet military and space programs to enhance the physical and mental performance of soldiers and astronauts.

Pharmacology

Bemethyl is an actoprotector, a type of drug that enhances physical performance and recovery after exercise. It works by increasing the body's resistance to physical and mental stress, improving the efficiency of energy production in the body, and enhancing the body's adaptive response to extreme conditions.

Bemethyl is not a stimulant and does not directly affect the central nervous system. Instead, it works by increasing the synthesis of adenosine triphosphate (ATP), the main energy source for cellular reactions, and enhancing the body's use of oxygen, which improves energy efficiency.

Medical uses

Bemethyl is used in the treatment of asthenia, a condition characterized by physical weakness or lack of energy. It is also used to enhance physical performance and recovery in athletes, and to improve cognitive function in individuals with cognitive impairments.

Side effects

The most common side effects of Bemethyl are mild and include nausea, headache, and insomnia. Rarely, it can cause allergic reactions.

Legal status

Bemethyl is not approved for use in the United States, but it is available in some countries, including Russia and Ukraine.

See also

• Nootropic
• Adaptogen
• Actoprotector
• Asthenia